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demonstrates antitoxin specificity and is coupled
to regulation of cell growth by a Soj-like protein
Melissa V Ramirez1, Clinton C Dawson1, Rebecca Crew1,3, Kathleen England1,2 and Richard A Slayden1*Abstract
Background: Molecular programs employed by Mycobacterium tuberculosis (Mtb) for the establishment of
non-replicating persistence (NRP) are poorly understood. In order to investigate mechanisms regulating entry into
NRP, we asked how cell cycle regulation is linked to downstream adaptations that ultimately result in NRP. Based
on previous reports and our recent studies, we reason that, in order to establish NRP, cells are halted in the cell
cycle at the point of septum formation by coupled regulatory mechanisms.
Results: Using bioinformatic consensus modeling, we identified an alternative cell cycle regulatory element,
SojMtb encoded by rv1708. SojMtb coordinates a regulatory mechanism involving cell cycle control at the point of
septum formation and elicits the induction of the MazF6 toxin. MazF6 functions as an mRNA interferase leading to
bacteriostasis that can be prevented by interaction with its cognate antitoxin, MazE6. Further, MazEF6 acts
independently of other Maz family toxin:antitoxin pairs. Notably, sojMtb and mazEF6 transcripts where identified at
20, 40 and 100 days post-infection in increasing abundance indicating a role in adaption during chronic infection.
Conclusions: Here we present the first evidence of a coupled regulatory system in which cell cycle regulation
via SojMtb is linked to downstream adaptations that are facilitated through the activity of the MazEF6 TA pair.
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A hallmark of Mycobacterium tuberculosis (Mtb) is its
ability to establish and maintain a latent infection
capable of resuming growth after long periods of time
during which no clinical symptoms of disease are evident.
This substantial reservoir of latent infections with the
potential for relapse to active disease and transmission
presents a significant obstacle for successful disease
management. Compounding this issue is the limited
number of treatment options for chronic tuberculosis
infections. Accordingly, there is a considerable need for
new anti-tuberculosis therapeutics capable of treating
both chronic and acute infections. However, before new
drugs with novel modes of action can be developed more* Correspondence: richard.slayden@colostate.edu
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stated.information about the coordination of adaptive metabolism
associated with latency needs to be obtained.
The transition from rapid growth to the non-replicating
persistent state (NRP) that is characteristic of chronic
tuberculosis infection involves the downshift of multiple
biological processes and a remodeled and reduced
metabolism [1]. Previous studies utilizing in vitro models
of Mtb NRP indicate the transition into this state occurs at
a specific point during the bacterial cell cycle [1-3]. While
these experimental observations highlight the required
coordination of cell cycle progression with cessation of
growth and metabolic shutdown, the precise regulatory
mechanisms coupling cell cycle regulation with downstream
global metabolic remodeling remain undefined.
Regulation of the cell cycle at the point of septum
formation is a key checkpoint in coordinating bacterial
stress responses and for transition into NRP [4-6]. The
SOS response, which prevents cell cycle progression in
response to DNA damage and other stresses, is a classic
example of cell division regulation under conditionall Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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Ramirez et al. BMC Microbiology 2013, 13:240 Page 2 of 12
http://www.biomedcentral.com/1471-2180/13/240stress [7-16]. Although proteins that regulate septum
formation have been widely characterized in other
bacterial species, proteins that carry out this function
have not all been identified or thoroughly characterized in
Mtb [17]. A previous study from our laboratory identified
a septum site determining protein, Ssd, and showed that
it is capable of regulating septum formation and
inducing alternative metabolic pathways, demonstrating a
relationship between the regulation of cell cycle progression
and the induction of molecular programs associated with
NRP [6].
There is growing evidence that genome encoded
toxin:antitoxin (TA) loci have important roles in Mtb
biology and they are increasingly being associated
with stress responses. TA loci encode an unstable
antitoxin immediately upstream of a toxin and these
proteins form a complex with one another under optimal
growth conditions. This interaction prevents the toxin
from exerting its effects on the specific cellular process it
targets [18,19]. Several environmental stresses are known
to result in the selective degradation of the antitoxin and
accumulation of free toxin [20-23]. Of the 88 putative TA
systems encoded in the Mtb genome, many have been
shown to be responsive to hypoxia, participate in growth
transitions, contribute to virulence, and regulate growth
in macrophages or in sputum [20,24-29]. Yet, their
regulation, coordination and specific contributions to
the many stressful states encountered by Mtb are not
fully understood [21,30].
Because of the large number of genome encoded TA
loci, and lack of information about their regulation and
interaction with other members of TA loci, our objective
was to identify a cell cycle regulatory component, that
was part of an alternative response that included TA loci,
and to asses the interaction of the TA loci components. In
this study, we identify SojMtb encoded by rv1708 as a cell
cycle regulatory protein that governs cell cycle progression
at the point of septum formation and elicits a complex
adaptive response that includes the MazEF6 TA loci of
Mtb. The MazF6 toxin is capable of inducing bacteriostasis
that can be inhibited by interaction with its cognate
antitoxin, MazE6. The MazEF6 TA pair form a stable
protein complex and MazF6 is not capable of interacting
with non-cognate antitoxins. This is the first report of a
coupled regulatory system consisting of a cell cycle
regulator, SojMtb, and a TA locus, that are involved in
a global adaptive response ultimately associated with
the transition into the NRP state of Mtb.
Results
ORF rv1708 encodes a Soj-like protein in Mtb
Previously, we used transcriptional mapping to assign
rv1708, originally annotated as a putative initiation
inhibition protein, as a septum formation regulatoryprotein [4]. To improve the functional assignment of
rv1708, a bioinformatics approach using a consensus
sequence derived from alignments of proteins with an
annotated function of septum inhibition was employed.
This substantiated the functional assignment of rv1708 as
encoding a septum regulatory protein because of shared
similarity with the septum regulatory protein MinD.
Septum inhibiting proteins, including MinD and Soj
proteins, belong to the same family of P-Loop ATPases
[31]. To narrow the functional assignment of Rv1708
we used the Phyre2 protein homology engine, which
successfully revealed that Rv1708 shares greater sequence
identity to Soj proteins (46% identity with 78% coverage; E
value 2e-82) than to true MinD proteins (27% identity
with 80% coverage; E value 6e-18). Alignments of the
Rv1708 protein with Soj and MinD consensus models,
Orthologous Matrix (OMA) groups 95838 and 78690
respectively, revealed that Rv1708 shares Soj-specific
DNA-binding residues while lacking the hydrophobic
C-terminal aliphatic helical extension that is involved
in membrane association and is characteristic of MinD pro-
teins [31,32] (Figure 1). Together, these analyses improve
the functional annotation and indicate that rv1708 encodes
an alternative Soj protein, referred to here as SojMtb.
Overexpression of sojMtb regulates cell cycle progression
and acts prior to septum formation
To assess whether SojMtb is involved in regulation of cell
cycle progression, we performed gene dosage experiments.
Overexpression of sojMtb caused a decrease in growth in
Mycobacterium smegmatis and Mtb compared to the
vector control strain (Figure 2). To visualize alterations in
cellular morphology due to overexpression of sojMtb,
mycobacterial cells were imaged using electron microscopy
(Figure 3). These studies revealed that overexpression of
sojMtb in M. smegmatis and Mtb produced similar elon-
gated cell phenotypes with a predominant ultra-structural
morphology absent of concentric rings indicative of septa.
This elongated cell phenotype is consistent with previous
studies performed in M. smegmatis [33]. The absence of
septa is characteristic of regulation of FtsZ polymerization
prior to Z-ring formation [4,5,16,34,35]. Together, these
data indicate that SojMtb reduces the frequency of septum
formation and governs cell cycle progression prior to
septum formation.
MazF6 toxin is elicited by SojMtb
To assess the involvement of SojMtb in eliciting alternative
adaptive responses, the global transcriptional response of
Mtb upon overexpression of sojMtb was investigated
through whole genome DNA microarray analysis. A total
of 1,368 genes from all functional categories displayed a
1.5 fold or greater change in expression (p values < 0.05)
in the Mtb merodiploid strain compared to the vector
Figure 1 Multialignment of Rv1708 with Soj and MinD consensus models. Blue shading indicates conserved residues while red shading
indicates residues involved in non-specific DNA binding by Soj proteins.
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analysis revealed that SojMtb is part of a large alternative
stress response based on the induction of alternative
sigma factors sigH, sigG, sigL, sigM, sigI in response to
overexpression of sojMtb. The pleotropic nature of this
transcriptional response is likely the result of the induction
of these alternative sigma factors, several of which have
been shown to regulate stress response pathways [36].
Notably, rv1991c encoding the MazF6 toxin of the
MazEF6 TA loci showed significant change in expression.
The MazF6 toxin is the most well characterized out of
nine predicted maz-family TA loci encoded in the Mtb
genome [20]. Molecular studies have demonstrated that the
MazF6 is an endoribonuclease that cleaves ACA mRNA
sequences, and that this activity is inhibited by interaction
with the MazE6 antitoxin [37]. MazF6 is thought to induce
rapid changes in the transcriptome due to its endoribonu-
clease activity, allowing coupling of cell cycle inhibition
by SojMtb and the transcriptional remodeling associated
with the transition into an alternative state such as NRP.
We compared the sojMtb response with previously
described programs associated with NRP in order to
determine if there was overlap in the transcriptional
responses. Overlap was determined by taking into account
the number of genes in the given transcriptional responseFigure 2 Overexpression of sojMtb slows growth of mycobacteria. Bact
pVV16 alone or (B) Mtb containing pVV16::sojMtb or pVV16 alone. Data inclu
independent experiments.in relation to the number of genes in the genome
(4,124 as indicated from the Broad Institute) to determine
the number of genes that would be shared only by chance,
as described previously [38]. There was no significant
degree of overlap between the up-regulated genes of the
sojMtb response and the dos-response or EHR (Table 1),
and in fact, the dos-response was actively down-regulated
(Table 2). However, there was significant overlap between
the sojMtb response and the “non-culturable” response,
with 14 up-regulated genes in common, the mazEF6
transcript among them.
MazE6 and MazF6 functionally and physically interact
To better understand the functional role of Maz-family
TA pairs, we sought to characterize the functionality and
interaction of MazE6 and MazF6. When expressed in vivo,
the MazF6 toxin induces bacteriostasis, while expression
of MazE6 causes no stalling of bacterial growth (Figures 4B
and 5A, respectively). Importantly, this bacteriostatic
phenotype can be rescued when the toxin and antitoxin
are co-expressed thus demonstrating a functional interaction
in vivo (Figure 5C). To show a physical interaction
between these two recombinant proteins, co-purification
was performed and protein identity was confirmed via
Western blot and mass spectrometry. When botherial growth curves of (A) M. smegmatis containing pVV16::sojMtb or
de technical replicates and are representative of three
Figure 3 Morphological characterization of mycobacteria overexpressing sojMtb. (A-B) M. smegmatis control and sojMtb merodiploid. (C-D)
Mtb control and sojMtb merodiploid.
Ramirez et al. BMC Microbiology 2013, 13:240 Page 4 of 12
http://www.biomedcentral.com/1471-2180/13/240antitoxin and toxin are produced individually and
subject to metal affinity chromatography, MazE6-HIS
is present in the elution fraction, while MazF6-HSV is
present in the unbound flow and wash fraction, indicating
that it is not retained in the affinity column (Figure 5D).
In contrast, when co-expressed, MazF6-HSV elutes primarily
with MazE6-HIS indicating that they physically interact
in vivo and that the bacteriostatic phenotype associated with
overproduction of MazF6 can be prevented by its interaction
with its cognate antitoxin, MazE6 (Figure 5). Western blot
analysis was confirmed by in-gel trypsin digestion of
the gel fragment corresponding to the recombinant
MazEF6 complex and identification by LTQ mass
spectrometry. MazEF6 were among the top hits returned
when searched against the NCBInr database for eubacteria.
MazE6 was identified with 70% coverage with 12
non-duplicate peptides, and MazF6 was identified with
95% coverage and 8 non-duplicate peptides.
To determine if there is any degree of functional
redundancy among the numerous MazEF loci in Mtb,
we assessed the interactions between MazF6 and non-
cognate MazE antitoxins. Functional redundancy was
assessed by the ability of non-cognate MazE antitoxins to
prevent bacteriostasis induced by MazF6. Growth arrest
due to MazF6-HSV production was not rescued by
co-production of non-cognate MazE-HIS antitoxins(Table 3). The MazF8 antitoxin encoded by rv2274a
was not tested because it is absent in some clinical
strains of Mtb [20,39]. Co-purification was also performed
and with all pairs tested, MazF6-HSV was only able to
physically interact with its cognate antitoxin, MazE6
(Figures 5D and 6). Our data confirm that the MazF6
toxin does not interact with non-cognate MazE antitoxins
in vivo indicating that there may be little functional
redundancy across MazEF pairs.
sojMtb and mazEF6 are expressed in bacteria in the lungs
and spleen of Mtb infected mice
Adaptations resulting in a NRP state have been associated
with the execution of complex and complementary
molecular programs designed to allow the cell to survive
the stresses experienced within the host [40]. These
include programs to slow bacterial growth, induce
alternative metabolic pathways, and to withstand acid,
hypoxic, nutrient and additional stresses. TA loci have
been associated with stress responses in bacteria and are
becoming the focus of increasing efforts to elucidate their
contributions to alternative states in vivo [18].
In order to determine if SojMtb and MazEF6 play a role
during infection, we assessed their transcriptional activity
during the infectious processes using the established mouse
model of infection [41]. Quantitative-PCR was used to
Figure 4 The global transcriptional response of Mtb upon overexpression of sojMtb organized by functional class. A total of 1,368 genes
from all functional categories displaying a 1.5 fold or greater change in expression (p values < 0.05) in the Mtb merodiploid strain compared to
the vector alone strain.
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from in vitro Mid-Log phase cultures, and the lungs and
spleen at 20, 40 and 100 days post-infection (Figure 7AB).
The analyses revealed an overall difference in expression
patterns and overall abundance of sojMtb and the mazEF6
loci as compared to in vitro grown bacteria. sojMtb was
abundant at day 20, 40, and 100. The transcriptional re-
sponse in the lungs was characterized by a significant
difference in the transcriptional abundance of mazE6 and
mazF6 at day 20, while this difference in the abundance of
mazE6 and mazF6 was not noted at days 40 and 100
(Figure 7A). Similarly to the transcriptional pattern ob-
served at day 20 in the lungs, in the spleen sojMtb wasTable 1 Comparisons of genes up-regulated upon
overexpression of sojMtb to previously described
responses associated with NRP
Response associated with NRP SojMtb response










(51 genes significantly up)
14 11
1[45], 2[39], 3[47].abundant at day 20, 40 and 100, and there was a two log or
greater difference in the abundance between mazE6 and
mazF6 throughout the course of infection (Figure 7B). The
observed transcriptional abundances observed between
mazE6 and mazF6 is consistent with observations of TA
loci in other systems [42]. Specifically, only the toxin
component of several TA loci were identified in Mtb in a
human macrophage model of late stage infection [43]. The
transcriptional activity of sojMtb, and mazE6 and mazF6 in
bacteria obtained from infected tissues indicate that MazF6
is important throughout the course of infection, and is
uniquely temporally functional in facilitating adaptations to
the alternative environments encountered during infection.Table 2 Comparisons of genes down-regulated upon
overexpression of sojMtb to previously described
responses associated with NRP
Response associated with NRP SojMtb response










(51 genes significantly up)
4 4
1[45], 2[39], 3[47].
Figure 5 MazE6-HIS antitoxin and MazF6-HSV toxin functionally and physically interact in vivo. A) Growth of E. coli BL21 (DE3) pLysE
containing MazE6-HIS alone, B) MazF6-HSV alone, or C) MazE6-HIS co-produced with MazF6-HSV. Growth arrest due to MazF6-HSV production is
recued by co-production of MazE6-HIS antitoxin. D) MazE6-HIS is present in the elution fraction, while MazF6-HSV is present in the unbound flow
and wash fraction when each is produced alone. When co-produced, MazF6-HSV elutes primarily with MazE6-HIS, indicating that they physically
interact. Data are representative of multiple independent experiments.
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The establishment of the NRP state requires the coordin-
ation of several important cellular processes. These include
the halting of cell cycle progression at the point of septum
formation, induction of alternative metabolic pathways, andTable 3 Growth kinetics in cultures co-expressing the












MazF6 alone - 46
MazE6 alone - 5
MazF6 6 4
Growth reduction associated with overexpression of the mazF6 toxin can be
rescued by co-expression of its cognate antitoxin. Full rescue of the growth
defect is not observed when co-expressed with non-cognate antitoxins.coordination of multiple regulatory mechanisms, including
TA loci, in modulating this adaptive response. Previous
studies have observed that during macrophage infection, as
well as under in vitro models of NRP, the bacteria are
observed as multinucleoidal smooth filaments, indicating
the transition into NRP occurs after chromosomal replica-
tion but prior to formation of the Z-ring septal precursor
[1-3]. Although proteins that carry out this function in Mtb
have not all been identified or characterized, we predicted
that they must be present in the Mtb genome, as this is a
critical checkpoint in the cell cycle. Homology searches for
cell division regulators known to act by inhibiting septum
formation identified rv1708 (sojMtb). Septum inhibiting
proteins including MinD, ParA and Soj, show extensive
similarity while participating in a variety of different cellular
processes [31]. Homology models and local sequence
alignments confirm that rv1708 encodes a Soj-like, rather
than MinD-like protein, as it contains the non-specific
DNA-binding residues highly conserved in Soj proteins but
lacking in MinD proteins [32]. While Soj and chromosomal
ParA proteins are considered to be equivalent in respect to
their roles in chromosome segregation, Soj proteins play an
important role in the regulation of sporulation-specific gene
expression and entry into stationary phase [44]. Previously,
Figure 6 MazF6-HSV toxin does not physically interact with non-cognate MazE-HIS antitoxins in vivo. With all pairs tested, MazE-HIS
antitoxins are present in the elution fractions, while MazF6-HSV is present in the unbound flow and wash fractions only, indicating that MazF6-HSV
is only able to physically interact with its cognate antitoxin, MazE6. From top to bottom, antitoxins tested are: MazE1 (Rv0456b), MazE2 (Rv0660c),
MazE3 (Rv1103c), MazE4 (Rv1494), MazE5 (Rv1943c), MazE7 (Rv2063), MazE9 (Rv2801a).
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encodes a ParA homolog [33]. However, based on genomic
context, we do not believe that the protein encoded
by rv1708 contributes significantly to chromosomal
segregation as ParA.
Together, our bioinformatic analysis and morphological
studies indicate a role in regulating cell division and
demonstrate that SojMtb performs a role in Mtb that
is analogous to Soj proteins described in other bacteria.SojMtb regulates the expression of a subset of genes that
act to establish a state of low metabolic activity and
reduced growth rate along with increasing adaptive
functions required for entry into NRP. Transcriptional
analyses of Mtb under a variety of conditions have
uncovered several molecular programs that have been
extensively linked to the NRP state of Mtb including
the dos (dormancy) response, the enduring hypoxic
response (EHR) and the “non-culturable” transitional
Figure 7 sojMtb and mazEF6 are expressed during infection. Quantative-PCR carried out on cDNA generated from RNA pools obtained from
Mid-Log phase Mtb and mouse (A) lungs and (B) spleen at day 20, 40, and 100 post-infection. sojMtb (rv1708) transcripts increased in abundance
throughout the course of infection in comparison to Mid-Log phase Mtb. mazEF6 (rv1991a, rv1991c) transcripts were identified at day 20, 40 and
100 infection in the lungs and spleen.
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septum site determining protein Ssd causes the induction
of alternative metabolic pathways, including the dos
regulon, further illustrating an intimate coordination
of cell cycle progression with induction of molecular
programs associated with NRP [6,45].
Upon overexpression of sojMtb, alternative sigma factors
sigH, sigG, sigL, sigM, sigI, and sigB are up-regulated. The
pleotropic nature of this transcriptional response is likely
the result of the induction of these alternative sigma
factors, several of which have been shown to regulate stress
response pathways [36]. In addition to the up-regulation of
alternative sigma factors, the greatest increase in gene
expression is seen for rv1991c, encoding the MazF6 toxin.
A 2009 study characterized the transition to NRP by
evaluating the “non-culturable” phenotype that has
been associated with dormancy in Mtb [47]. Notably,
mazF6 was significantly up-regulated in this physiological
model. In fact, there is significant overlap in the differential
expression patterns between the “non-culturable” response
and the response observed upon overexpression of sojMtb.
There was no significant degree of overlap between
the up-regulated genes of the sojMtb response and the dos
response or EHR, and in fact, the dos response was
actively down-regulated. The dos response contributes
to the preparation of Mtb for NRP, while the EHR
contributes to the maintenance of NRP [46]. Although the
dos response has been shown to aid in the adaptation to
low oxygen state associated with NRP, mutants in the
response have shown varying degrees of phenotypes and
suggest that it does not play as prominent a role in NRP
as once thought [38]. This further supports the role of the
sojMtb response in preparing the bacterium for alternative
conditions in a manner that is distinct from the preparation
elicited by the dos response. Therefore, we posit that MazF6
functions to facilitate the transition into NRP. Likely, the
endoribonuclease activity of MazF6 is utilized to erase
the existing transcriptome to free cellular machinery to
produce transcripts needed for successful entry into NRP.Currently, there are nine predicted maz-family TA loci
encoded in the Mtb genome [20]. Despite a number of
reports, the information about the interaction of cognate
and non-cognate Maz-family TA pairs is limited [49]. In
this study we have demonstrated that the MazF6 toxin is
capable of inducing bacteriostasis and that this state can
be inhibited by interaction with its cognate antitoxin,
MazE6. In addition, we have confirmed a physical
interaction between these two proteins by purifying the
proteins in complex from live cells. We have also shown
that the interaction is specific and that MazF6 is not
capable of interacting with non-cognate antitoxins. This
suggests that although there are a high number of TA loci
in Mtb, cross-talk via interaction is unlikely to occur, at
least among this family of TA pairs. The identification of
both sojMtb and mazEF6 transcripts in bacteria isolated
from the lungs and spleen of infected mice further
supports the role of sojMtb and this toxin in facilitating the
transition to alternative host environments through a
coupled regulatory mechanism. The unique differential tem-
poral profile of transcriptional abundance of the mazEF6
polycistron throughout the host infection is concordant
with previous observations. Post-transcriptional regulation
of TA loci that are co-transcribed is a complex dynamic
phenomenon that results in the accumulation of the toxin
component of the bicistronic mRNA during times of envir-
onmental stress. A study of Mtb during human macrophage
infection identified only the toxin component of several TA
orthologs during late stage infection [43]. Similarly, a study
in E. coli substantiated post-transcriptional modification of
endogenous mazEF mRNA in the presence of RelE toxin
resulting in the accumulation of mazF toxin mRNA [42].
Together with previous reports, our data indicate that
regulation of TA loci is not strictly occurring at the post-
translational level but also at the post-transcriptional level.
Conclusions
All environmental conditions or cellular processes that
induce the accumulation of the toxin component of TA
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fully elucidated. The identification of SojMtb, whose
overproduction elicits the induction of this particular
toxin loci, links the halting of cell division prior to
the point of septum formation to molecular programs
associated with alternative responses. MazF6 is strongly
up-regulated upon overproduction of SojMtb, suggesting
that the regulation of cell division and its eventual halting
is facilitated through the action of this toxin. This is the
first report of a coupled regulatory system that links
cell cycle regulation by SojMtb molecular programs
associated with adaptation to stress in Mtb via the
activity of MazEF6 TA loci. Importantly, this information
provides a foundation for further analysis of how TA
loci are coordinated with regards to other essential
cellular processes and to define their contribution to
the establishment of the NRP state of Mtb.Methods
Bioinformatic analysis
To identify putative cell division regulators in Mtb,
consensus models were derived from septum formation
inhibitors from OMA groups 78690, 63437, 84083, 90270,
and 245137–40 from a variety of bacterial species using a
MAFFT local multialignment tool. Resulting consensus
sequences were used to BLAST the Mtb H37Rv genome
to identity mycobacterial ORFs that encode septum
regulatory proteins. BLAST searches were optimized
for percent identity and score. Top hits were analyzed
by the Phyre2 server to confirm or refute identification as
putative septum formation inhibitors.Generation of recombinant mycobacterial strains
For all mycobacteria experiments, Mtb strain H37Rv
(ATCC 27294) and M. smegmatis mc2155 was cul-
tured at 37°C with shaking in Middlebrook 7H9 liquid
medium containing 0.4% glycerol, 10% OADC, and
0.05% Tween80 or on Middlebrook 7H10 agar containing
0.4% glycerol and OADC containing appropriate anti-
biotics as noted. For generation of recombinant mycobac-
terial strain overexpressing sojMtb, the rv1708 gene was
PCR amplified from Mtb H37Rv genomic DNA using
AccuPrimePfx DNA polymerase (Invitrogen) and
cloned into the NdeI and HindIII of the pVV16 con-
stitutive, extrachromosomal mycobacterial vector,
which is a derivative of pMV261 [50,51] (Additional
file 1). DNA constructs were transformed into One
Shot® TOP10 chemically competent E. coli (Invitrogen)
and selected by growth on LB agar containing 50 μg ml-1
kanamycin. Sequence confirmed plasmid DNA was
transformed into electrocompetent M. smegmatis or
Mtb and selection was carried out using kanamycin at
25 μg ml-1.Microscopy and ultrastructural analysis by SEM
Recombinant M. smegmatis strains containing the
bacterial shuttle vector pVV16 as a control and sojMtb::
pVV16 were grown to an O.D.600nm of 1.0 and collected
by centrifugation. Cells were washed three times in PBS,
pH 7.4, and fixed with 2.5% glutaraldehyde in Buffer A
(0.1 M potassium phosphate (pH 7.4), 1 mM CaCl2 and
1 mM MgCl2) at 4°C for 48 hrs. The fixed bacterial cells
were collected by centrifugation, washed three times in
Buffer A and treated with 1% OsO4 in Buffer A for
30 minutes at 4°C. Again, cells were washed three
times with Buffer A. and prepared for SEM with a graded
series of ethanol treatments (20-100%). Ultrastructural
examination was performed using a JOEL JEM -100CX
electron microscope. Recombinant Mtb strains containing
the bacterial shuttle vector pVV16 as a control and
pvv16::sojMtb were prepared as described above. However,
the pvv16::sojMtb culture did not reach an O.D.600nm of 1.0
and was prepared once the growth had plateaued.
Isolation of total RNA for microarray analysis, microarray
processing, and data analysis
At Mid-Log growth, Mtb cells were harvested by centri-
fugation and resuspended in TRIzol (Invitrogen). Cells
were lysed by bead beating for one-minute increments for
three minutes total, cooling the sample on ice between each
step. RNA was separated from other cellular products by
the addition of chloroform and centrifugation, according to
the TRIzol protocol. The upper aqueous layer was
combined with an equal volume of 70% ethanol, and
the entire volume was applied to an RNeasy Mini kit
(Qiagen) column for RNA cleanup.
The Mtb whole genome microarrays were obtained
through the TB Research Materials and Vaccine Testing
Contract at Colorado State University. Slides were
post-processed using succinic anhydride as described
previously [4]. Approximately 8 μg of total RNA was
converted to cDNA in the presence of either Cy5- or
Cy3-labeled nucleotides as previously described [4,6].
Hybridization was performed at 42°C for 12 hr. Slides
were scanned using an Axon Genepix scanner. The final
microarray data set (Additional file 2) resulted from
combining independent biological replicates. Data reduc-
tion and global normalization was performed on the raw
fluorescent intensities. The normalized intensity values of
treated and control cultures were used to generate ratio
and log2 expression values for each gene.
MazF6 interaction analysis
For the Maz6 TA loci interaction studies, mazE and
mazF gene fragments were PCR amplified from Mtb
H37Rv genomic DNA using Phusion® High-Fidelity PCR
Master Mix with GC Buffer (New England BioLabs Inc.).
Generally, mazE antitoxins were cloned in the BamHI and
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toxin was cloned into the SphI and NotI restriction
sites of pETcoco2 (Novagen) (Additional file 1). DNA
constructs were transformed into One Shot® TOP10
chemically competent E. coli (Invitrogen) or Z-Competent
E. Coli - Strain DH5α (Zymo Research) and transformants
selected by growth on LB agar containing 50 μg ml-1
kanamycin for pET28a and 50 μg ml-1 ampicillin for
pETcoco2. Sequence confirmed plasmid DNA was
transformed into One Shot® BL21(DE3) pLysE Chemically
Competent E. coli (Invitrogen) and selection was carried
out overnight by growth in LB broth supplemented with
0.2% glucose, 34 μg ml-1 chloramphenicol, and containing
50 μg ml-1 kanamycin for pET28a selection or 50 μg ml-1
ampicillin for pETcoco2 selection, or both in cases of
co-transformation. Glucose was added to the media
to maintain low basal expression from the pET vectors as
previously described [52]. The overnight outgrowths were
used for recombinant protein induction. Briefly, cultures
were diluted back 1:50 in fresh media containing antibiotics
without glucose. When mazF6::pETcoco2 construct was
used, diluted cultures were grown for one hour with shak-
ing at 37°C and L-arabinose was added to a final concentra-
tion of 0.01% to amplify plasmid copy number prior to
protein induction. Once cultures reached Mid-Log, protein
production was induced using 1 mM final concentration of
isopropyl-beta-D-thiogalactopyranoside (IPTG)(Fermentas).
Cultures were incubated for four hours with shaking at
37°C, with timepoints being taken every hour to monitor
growth by O.D.600nm. After four hours, bacterial cell pellets
were collected by centrifugation and stored at −80°C.
Purification of MazE-HIS in complex with MazF6-HSV
was carried out under native conditions to maintain
protein-protein interactions. Cleared lysates of bacterial
cell pellets were obtained using BugBuster® including
Benzonase® (Novagen) according to manufacturer’s instruc-
tions. Generally, cleared lysate was combined with
one-fourth the volume of Ni-NTA His-Bind® Resin
and mixed gently at 4°C for 1 hour before packing
into a column. The column was washed with wash
buffer 1 (500 mM NaCl, 20 mM Tris–HCl, 60 mM
imidazole, pH 9.0), followed by wash buffer 2
(250 mM NaCl, 20 mM Tris–HCl, 100 mM imidazole,
pH 9.0). Recombinant protein or protein complexes were
eluted with elution buffer (250 mM NaCl, 20 mM
Tris–HCl, 300 mM imidazole, pH 9.0). All fractions
were collected and samples were resolved using pre-cast
12% NuPAGE® gels (Invitrogen), followed by transfer to
0.2 micron nitrocellulose membrane (BioRad) for Western
blotting. Membranes were blocked in 4% BSA in TBST,
incubated with primary Penta-His antibody (Qiagen) or
anti-HSV antibody (Novagen), both diluted 1:10,000,
followed by goat anti-mouse-alkaline phosphatase (Sigma)
secondary antibody diluted 1:10,000. Membranes weredeveloped using SIGMAFAST™ BCIP®/NBT tablet (Sigma)
according to manufacturer’s instructions.
Mouse infection, bacterial quantification, and RNA
isolation
All use of vertebrate animals took place at Colorado
State University, which is AAALAC approved and has
an OLAW number of A3572-01. Care was provided by
veterinarians in the Laboratory Animal Resources of
Colorado State University under the supervision of the
University Veterinarian. Six week-old female C57BL/6
mice (Jackson Laboratories) were infected via low dose
aerosol with Mtb H37Rv in a Glas-Col Inhalation Exposure
System (Glas-Col, Inc.). Exposure was conducted by
aerosolizing approximately 2×106 cfuml-1 in a volume
of 5 cubic feet over a period of 30 minutes, followed
by a 20 minute period of cloud decay. Infected mice
were housed in sterile micro-isolator cages in the
ABSL-3 facility at Colorado State University and provided
water and food ad libitum and monitored for morbidity.
Five animals per time point were sacrificed at 20, 40, and
100 days post-infection by CO2 inhalation and lungs and
spleens were harvested. Organs were cut into halves, and
half of each organ was homogenized in 2 mL sterile saline
using an Omni Tissue homogenizer (Omni International).
Bacterial burden in the lungs and spleen at each time
point were assessed by plating 10-fold serial dilutions
of organ homogenates on Middlebrook 7H11 agar con-
taining 10% OADC and carbenicillin (Sigma) and cyclohex-
imide (Sigma) at 50 μg ml-1 and 10 μg ml-1, respectively.
Plates were incubated at 37°C for three weeks.
The remaining half of each lung and spleen were
homogenized in 5 ml TRIzol by bead beating. Total
RNA was isolated by organic phase separation. RNA
samples were treated with DNAse (Fermentas) for 1 hour
at 37°C, re-extracted in phenol/chloroform/isoamyl alcohol
(25:24:1)(Sigma), and precipitated with ammonium acetate.
Reverse transcription and quantitative-PCR
cDNA synthesis from total RNA from the lungs and
spleen of infected mice was carried out using a
gene-specific reverse primer cocktail with Transcriptor
First Strand cDNA Synthesis Kit (Roche). The reverse
primer cocktail contained reverse primers specific for
mazE6, mazF6, and sojMtb in addition to random hexamers
(Additional file 3). Reactions contained 1 μg total RNA,
2.5 μM gene-specific reverse primers, and 60 μM random
hexamers. cDNA synthesis were carried out according
to manufacturer instructions along with no reverse
transcriptase control and no template control reactions.
Quantative-PCR was carried out using 50 ng of cDNA
generated from RNA isolated from Mid-Log phase Mtb,
and RNA isolated from lungs and spleens of mice at Day
20, 40,and 100 post-infection. Calibration curves were
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specific dsDNA amplicons generated from PCR using
GoTaq®Green Master Mix (Promega). Calibration curves of
respective dsDNA amplicons ranged from 1 ng to 1-8 ng
per reaction in 10-fold serial dilutions. Modeled linear
fits and primer efficiencies were used to determine
concentration of respective gene. Amplicons in experimen-
tal samples were converted to total mRNA copy number
per mL. Each sample was normalized by taking total
mRNA copy number per mL and dividing by the associated
cfu mL-1 recovered from each biological sample. No reverse
transcriptase and no template controls confirmed no gDNA
contamination or non-specific amplification.
Additional files
Additional file 1: Primer sequences used for plasmid construction.
Additional file 2: Differential gene expression of Mtb upon
overexpression of sojMtb.
Additional file 3: Primer sequences used for end-point PCR.
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